Articles

Out of Order: Of mice and…well…other mice

Trying to present the news without too much fanfare (and with maximum accuracy) means resisting temptation, but it's effort well-spent
Written byRandall C Willis
| 3 min read

As someone who routinely writes about biomedical science and its potential to change the way humans live and interact, it is tempting to let the excitement of an achievement overwhelm any discussion of its cautionary aspects or its limitations. Every step offers so much hope to people who have worked so hard to achieve that step, and particularly to the people who await relief from a medical condition or its related anxiety.

Similarly, in trying to convince inquiring minds to pick up the latest issue of DDNews or to click on a story link or like and retweet our social media posts, it is tempting to write the headline that induces excitement or intrigue. Like any news organization, DDNews is a business and that business requires readers.

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

Here are some related topics that may interest you:

Published In

Volume 15 - Issue 5 | May 2019

May 2019

May 2019 Issue

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Illustration of multiple three-dimensional patient-derived organoids suspended against a dark blue background, representing tumor models used in precision oncology research.
By combining organoid biology with precision automation, researchers developed a miniaturized organoid screening platform that could help speed personalized cancer treatment testing.
Illustration of multiple three-dimensional patient-derived organoids suspended against a dark blue background, representing tumor models used in precision oncology research.
By combining organoid biology with precision automation, researchers developed a miniaturized organoid screening platform that could help speed personalized cancer treatment testing.
3D illustration of a membrane protein embedded within a lipid nanodisc, representing a native-like environment used for membrane protein stabilization and characterization.
Mass photometry supports membrane protein characterization by providing rapid insights into sample composition, purity, and molecular assembly.
Drug Discovery News December 2025 Issue
Latest IssueVolume 21 • Issue 4 • December 2025

December 2025

December 2025 Issue

Explore this issue